Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

164
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
164
Surface Membrane Barriers01:18

Surface Membrane Barriers

3.0K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
3.0K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

2.3K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

5.0K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.0K
Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

1.6K
Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
1.6K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

84
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
84

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic review: Safety of surgical male circumcision in context of HIV prevention public health programmes.

Gates open research·2023
Same author

Contribution of Maternal Antiretroviral Therapy and Breastfeeding to 24-Month Survival in Human Immunodeficiency Virus-Exposed Uninfected Children: An Individual Pooled Analysis of African and Asian Studies.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2017
Same author

Developing a forward-looking agenda and methodologies for research of self-use of medical abortion.

Contraception·2017
Same author

Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.

Journal of acquired immune deficiency syndromes (1999)·2017
Same author

Innovative Methods of Male Circumcision for HIV Prevention-Getting the Right Evidence.

Journal of acquired immune deficiency syndromes (1999)·2016
Same author

Corrigendum to "Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A" [Contraception 2016;93:498-506].

Contraception·2016

Related Experiment Video

Updated: Apr 26, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.3K

Preparing for microbicide introduction, rollout, and sustained access.

Cynthia Woodsong1, Elizabeth McGrory, Tim Farley

  • 1International Partnership for Microbicides, Silver Spring, MD, 20910, USA, cwoodsong@ipmglobal.org.

Current Topics in Microbiology and Immunology
|July 21, 2014
PubMed
Summary

Two vaginal microbicide candidates for HIV prevention are nearing completion of clinical trials. Preparations are underway to ensure women’s access to these potential new HIV prevention tools if proven safe and effective.

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

4.4K
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

13.9K

Related Experiment Videos

Last Updated: Apr 26, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.3K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

4.4K
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

13.9K

Area of Science:

  • Public Health
  • Infectious Disease Prevention
  • Women's Health

Background:

  • Two topical vaginal microbicides for HIV prevention are in advanced clinical trials.
  • Efficacy results from three trials are anticipated within two years.
  • Microbicides represent a critical public health need for female HIV prevention.

Purpose of the Study:

  • To highlight preparatory work for the introduction of microbicide products.
  • To discuss actions needed to ensure product accessibility for women.
  • To emphasize the importance of collaboration and investment for new public health technologies.

Main Methods:

  • Review of work by scientists, advocates, and public health officials since 2000.
  • Analysis of the development landscape for microbicide candidates.
  • Identification of requirements for successful product introduction and access.

Main Results:

  • Significant progress has been made in preparing for microbicide introduction.
  • Minimal involvement of commercial pharmaceutical partners in development.
  • Substantial leadership, political commitment, and financial investment are crucial.

Conclusions:

  • Ensuring women's access to effective microbicides requires proactive planning and collaboration.
  • The successful introduction of this new product class depends on broad expertise and sustained commitment.
  • Continued efforts are needed to make these vital HIV prevention tools readily available to women.